How much is tirzepatide in the UK, and what should that price actually include?

Why does the price of tirzepatide differ between providers?

The short answer is that different services bundle different things. The medicine itself has a list price set by Eli Lilly, but what private providers charge is shaped by what they wrap around it. A lower headline figure often reflects that the consultation, the prescription, and delivery are charged separately, or that aftercare is thin to nonexistent. When you compare prices, you are rarely comparing the same product.

A useful way to approach this: Eli Lilly's UK list price for tirzepatide rose significantly from 1 September 2025, with the highest-dose pen moving from roughly £122 to around £330. Private providers set their own prices above that, and if you want a fuller picture of how much tirzepatide costs across different service models, the range reported since has been roughly £149 to £375 a month depending on dose and service model. Those figures are worth knowing as context, but they do not tell you what you are actually getting.

The dose also matters. Treatment starts at 2.5mg, the starter strength exists so your body adjusts gradually, not because it is where most people stay. Typical private pricing is tiered, so understanding how much tirzepatide per week you are likely to use will affect what you pay at 5mg or 10mg compared to the entry figure. Our tirzepatide pricing page has more on how the dose structure shapes cost over time.

What do headline tirzepatide prices typically leave out?

This is the question most people do not think to ask until something goes wrong. A number of online services separate the clinical consultation from the treatment price, meaning you pay once to be assessed and again to receive the medicine. Others charge a delivery fee per pen. Some levy a prescription fee. A few operate on subscription models where ongoing charges continue unless you actively cancel.

Aftercare is another variable. Clinical questions arise during treatment, about how to handle side effects, what to do if a dose is delayed, or whether a dose increase is appropriate. A service that sells you a pen and leaves you to figure the rest out is not the same as one with seven-day prescriber access built in.

For context on how these costs stack up across the dose schedule, the tirzepatide cost breakdown page runs through what you might realistically spend across a full titration pathway.

Where does nume sit on price, and why is that a deliberate choice?

We are not the cheapest option. That is a considered position, not an oversight.

What we charge covers the consultation, the prescription, the medicine, and free next-working-day tracked delivery, DPD, with tracking to your phone, in a plain box that says nothing about what is inside. There are no add-on fees, no subscription, and no auto-renewal. Every repeat order goes back in front of a prescriber for clinical review before it goes anywhere near a courier.

Our clinical team, including our lead prescriber Mostafa Damghani, reviews every consultation personally. That detail matters because the alternative (software that processes applications and flags outliers) is not how a prescription for a medication like this should work, in our view or in the MHRA's.

Current treatment pricing is on our weight-loss treatments page. We do not print per-pen prices in editorial content, and we do not run discount codes, voucher campaigns or promotional pricing on prescription medicines.

Why 'cheapest' is the wrong question to ask about a prescription medicine

Price is a reasonable thing to research. But for a prescription-only medicine, the cheapest listing often answers the wrong question.

The MHRA has issued repeated warnings about fake tirzepatide and semaglutide pens circulating online, including the discovery in October 2025 of an illicit UK manufacturing site producing counterfeit tirzepatide pens. Fake pens have contained insulin. It is also worth understanding how much is too much tirzepatide, because unsafe sourcing raises the risk of receiving incorrectly dosed or counterfeit products, and the safe purchase route is a pharmacy you can verify: check the GPhC register entry for our pharmacy directly. Any seller offering these medicines without a full clinical assessment, or with unusually low pricing well outside the reported market range, is a red flag.

NICE's appraisal of tirzepatide, TA1026, sets out the clinical criteria under which this medicine is recommended, it is a specific intervention, not a quick fix. Choosing a provider on price alone, without checking clinical standards, GPhC registration, and what actually happens when you have a question, is a risk that a small saving does not justify.

If you have questions about whether tirzepatide is right for you, or how the process works, our FAQs page covers the most common ones, or you can reach our team directly.